emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университет10.51922/2616-633X.2021.5.2.1329emcardio-172Research ArticleОригинальные научные публикацииOriginal Scientific ResearchРезультаты трансплантации сердца в зависимости от степени гипертрофии миокарда левого желудочка донорского сердцаThe results of heart transplantation depending on the severity of the left ventricular myocardial hypertrophy of the donor heartСпиридоновС. В.SpiridonovS. V.ТретьяковД. С.TretyakovD. S.БулавскаяП. Е.BulavskayaP. E.ВалентюкевичА. В.ValentyukevichA. V.ДубовикТ. А.DubovikT. A.МанкевичН. В.MankevichN. V.ОстровскийЮ. П.OstrovskyYu. P.Республиканский научно-практический центр «КардиологияRepublican Scientific and Practical Center CardiologyБелорусский государственный медицинский университетBelarusian State Medical University202124102025521329–1337Copyright © Спиридонов С.В., Третьяков Д.С., Булавская П.Е., Валентюкевич А.В., Дубовик Т.А., Манкевич Н.В., Островский Ю.П., 20252025Спиридонов С.В., Третьяков Д.С., Булавская П.Е., Валентюкевич А.В., Дубовик Т.А., Манкевич Н.В., Островский Ю.П.Spiridonov S.V., Tretyakov D.S., Bulavskaya P.E., Valentyukevich A.V., Dubovik T.A., Mankevich N.V., Ostrovsky Y.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/172

В статье рассматривается влияние гипертрофии левого желудочка (ЛЖ) донора на выживаемость реципиентов после трансплантации сердца

The article discusses the impact of donor left ventricular (LV) hypertrophy on the survival of recipients after heart transplantation.

трансплантация сердцагипертрофия левого желудочкарасширение пула доноровReferencesAziz S, Soine LA, Lewis SL, et al. Donor left ventricular hypertrophy increases risk for early graft failure. TransplInt 1997; 10: 446– 450.Aziz S, Soine LA, Lewis SL, et al. Donor left ventricular hypertrophy increases risk for early graft failure. TransplInt 1997; 10: 446– 450.Kuppahally SS, Valantine HA, Weisshaar D, et al. Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Am J Transplant 2007; 7: 2388–2395.Kuppahally SS, Valantine HA, Weisshaar D, et al. Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Am J Transplant 2007; 7: 2388–2395.Goland S, Czer LS, Kass RM, et al. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. J Am CollCardiol 2008; 51: 1214–1220Goland S, Czer LS, Kass RM, et al. Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. J Am CollCardiol 2008; 51: 1214–1220Lang RM, Bierig M, Devereux RB, et al., for Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J AmSocEchocardiogr2005;18:1440–63Lang RM, Bierig M, Devereux RB, et al., for Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J AmSocEchocardiogr2005;18:1440–63Marelli D, Laks H, Fazio D, Moore S, Moriguchi J, Kobashigawa J. The use of donor hearts with left ventricular hypertrophy. J Heart Lung Transplant 2000;19:496–503.Marelli D, Laks H, Fazio D, Moore S, Moriguchi J, Kobashigawa J. The use of donor hearts with left ventricular hypertrophy. J Heart Lung Transplant 2000;19:496–503.Aziz S, Soine LA, Lewis SL, et al. Donor left ventricular hypertrophy increases risk for early graft failure. TransplInt1997;10:446–50.Aziz S, Soine LA, Lewis SL, et al. Donor left ventricular hypertrophy increases risk for early graft failure. TransplInt1997;10:446–50.Sorel Goland et al. Use of Cardiac Allograf ts With Mild and Moderate Lef t Ventricular Hypertrophy Can Be Safely Used in Heart Transplantation to Expand the Donor Pool Journal of the American College of Cardiology Vol. 51, No. 12, 2008Sorel Goland et al. Use of Cardiac Allograf ts With Mild and Moderate Lef t Ventricular Hypertrophy Can Be Safely Used in Heart Transplantation to Expand the Donor Pool Journal of the American College of Cardiology Vol. 51, No. 12, 2008O. WeverPinzon et al. Impact of Donor Left Ventricular Hypertrophy on Survival After Heart Transplant American Journal of Transplantation 2011; 11: 2755–2761O. WeverPinzon et al. Impact of Donor Left Ventricular Hypertrophy on Survival After Heart Transplant American Journal of Transplantation 2011; 11: 2755–2761Kittleson M. et al. Donor Left Ventricular Hypertrophy: Over-Rated or Does Donor History of Hypertension Make a Difference for Post-Heart Transplant Outcome? J Heart Lung Transplant V. 38, Issue 4, S269, April 01, 2019 DOI:https://doi.org/10.1016/j.healun.2019.01.670Kittleson M. et al. Donor Left Ventricular Hypertrophy: Over-Rated or Does Donor History of Hypertension Make a Difference for Post-Heart Transplant Outcome? J Heart Lung Transplant V. 38, Issue 4, S269, April 01, 2019 DOI:https://doi.org/10.1016/j.healun.2019.01.670Попцов В.Н., Спирина Е.А., Устин С.Ю., Масютин С.А., Догонашева А.А., Воронков В.Ю. и др. Трансплантация донорского сердца с гипертрофией миокарда левого желудочка 1,5 см и более. Вестник трансплантологии и искусственных органов. 2019;21(1):7–16Попцов В.Н., Спирина Е.А., Устин С.Ю., Масютин С.А., Догонашева А.А., Воронков В.Ю. и др. Трансплантация донорского сердца с гипертрофией миокарда левого желудочка 1,5 см и более. Вестник трансплантологии и искусственных органов. 2019;21(1):7–16

The authors declare that there are no conflicts of interest present.